~~<i id='22866C9EF7'><strike id='22866C9EF7'><tt id='22866C9EF7'><pre id='22866C9EF7'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：knowledge 2025-09-29 08:42:45 Page View：91

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 'CMA Fest' 2023: How to watch, who is performing and more
Next article： Anesthesiologist group: stop taking Ozempic before surgery

focus

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

In rare move, senator releases unverified FBI source report alleging Biden bribe

4:19Sen.ChuckGrassleyisseenoutsidetheRepublicansenateluncheonattheCapitolastheSenateworksonthedebtli

Guidelines to prevent youth baseball injuries need more muscle

Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

'CMA Fest' 2023: How to watch, who is performing and more

3:13LukeCombsisshownatCMAFest2023,onJune8,2023,inNashville,Tenn.|RebaMcEntireandMirandaLambertaresho